Does early adolescent binge drinking (BD) increases the risk for and/or severity of psychopathology in post-9/11 veterans, and how does mild traumatic brain injury (mTBI) affect the risk?
BETHESDA, MD—Researchers at the National Institute on Drug Abuse (NIDA) had been fighting one daunting national health crisis already when the COVID-19 pandemic launched its attack on the U.S. Now, these federal scientists face the dual challenges of reducing the...
LITTLE ROCK, AR—More isn’t necessarily better when it comes to opioid treatment. That was the somewhat surprising finding of a study focusing on veterans with chronic pain related to arthritis, back pain, neck pain, neuropathic pain or headache/migraine. A report in...
Unrecognized by many in healthcare is that the greatest increases in long-term opioid use and opioid-related overdose mortality in recent years have been among women in midlife.
SEATTLE — Symptoms of insomnia and anxiety are common among patients with chronic obstructive pulmonary disease, and that is especially the case among patients with comorbid mental health disorders such as posttraumatic stress disorder, according to a new study.
WASHINGTON — A VA panel this summer opted not to add the new depression medication esketamine, Spravato, to the department’s formulary in the usual way. This came despite strong support from President Donald Trump and an effort by VA officials to fast-track the drug for approved use at VA facilities.
FALLS CHURCH, VA — In June 2018, Defense Health Agency Director Raquel Bono, MD, directed all MHS pharmacies to dispense the opioid reversal agent naloxone to eligible beneficiaries and those who request it without requiring a prescription. Since then, MHS pharmacists have provided more than 6,200 kits.
Extended Prescribing Dropped from 9.5% in 2012 to 6.2% in 2016
By Brenda L. Mooney
IOWA CITY, IA—Long-term prescribing of opioid painkillers is on the decline at the VA, in contrast to what appears to be happening outside of federal medicine.